A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19

Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4.

Authors

Philip Keith¹, Matthew Day², Linda Perkins², Lou Moyer², Kristi Hewitt², Adam Wells³

Affiliations

¹ Critical Care Medicine, Lexington Medical Center, 2720 Sunset Boulevard, West Columbia, SC, 29169, USA. Pkeith97@yahoo.com.
² Critical Care Medicine, Lexington Medical Center, 2720 Sunset Boulevard, West Columbia, SC, 29169, USA.
³ Critical Care Medicine, Novant Health Forsyth Medical Center, 3333 Silas Creek Parkway, Winston Salem, NC, 27103, USA.

No abstract available

Publication types

Editorial

MeSH terms

Betacoronavirus
Biomarkers / blood
COVID-19
COVID-19 Serotherapy
Coronavirus Infections / diagnosis
Coronavirus Infections / therapy*
Humans
Immunization, Passive
Pandemics / prevention & control
Plasma Exchange / methods*
Pneumonia, Viral / diagnosis
Pneumonia, Viral / therapy*
Respiration, Artificial
SARS-CoV-2
Severe Acute Respiratory Syndrome

Substances

Biomarkers